U.S. Markets closed

WeedMD Inc. (WDDMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1914-0.0036 (-1.85%)
At close: 3:53PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1950
Open0.2500
BidN/A x N/A
AskN/A x N/A
Day's Range0.1843 - 0.2500
52 Week Range0.1783 - 1.0000
Volume51,107
Avg. Volume101,715
Market Cap40.102M
Beta (5Y Monthly)1.15
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • WeedMD Appoints Seasoned HR Executive to Chief People Officer
    GlobeNewswire

    WeedMD Appoints Seasoned HR Executive to Chief People Officer

    Deborah Sikkema appointed Chief People Officer to lead the Company’s newly-integrated talent, culture and organizational development initiatives WeedMD Appoints Seasoned HR Executive to Chief People Officer Deborah Sikkema, Chief People Officer, leads newly-integrated talent, culture and organizational development initiatives. Spearheads WeedMD's continued drive to be an employer of choice and a model for diversity, inclusion and accountability. TORONTO, Oct. 20, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis is pleased to announce the appointment of seasoned human resources (HR) executive Deborah Sikkema as the Company’s Chief People Officer.A multi-faceted business leader with 20 years of HR experience in some of Canada’s top-tier organizations, such as Shoppers Drug Mart, Canadian Tire, and Holt Renfrew, Deborah is also appointed to WeedMD’s Compensation Committee alongside its Board of Directors (the “Board”).In addition to Deborah’s appointment, the Company and the Board have also affirmed Stephen Ng as Chief Commercial Officer. He previously held the position of Chief Strategy Officer of WeedMD and Chief Financial Officer of Starseed Medicinal Inc.“This has been a transformative year for our employees and our industry. Our valued employees are our single greatest resource which defines who we are as a company and under Deborah’s leadership, teams have integrated seamlessly,” said Angelo Tsebelis, CEO of WeedMD. “We’re thrilled to welcome her as a permanent member of our team as we continue building the business for commercial success. Both Deborah and Stephen are inspirational leaders and strategic thinkers who bring valuable expertise at a critical juncture as we build teams to expand our product offerings and leverage our unique distribution platforms to drive organic growth.”“WeedMD is known throughout the cannabis sector as an employer of choice committed to developing its talent and communities for continued results in the quality production of innovative products,” said Ms. Sikkema. “Our highly-engaged employees provide us with a sustainable competitive advantage that will take us to the next level of success. I’m proud to be leading our initiatives that marry our core values with our drive to be a model for diversity and inclusion, accountability, and social responsibility, as we foster commercial achievements in this growth stage.”Prior to permanently joining WeedMD, Deborah spent the previous six months, under consultation, overhauling the Company’s HR department and people strategy. With her guidance, the Company established employee development and goal-setting programs to make WeedMD a ‘living wage’ employer, introduced protocols for business integration and cultural transformation, overhauled its benefits plan to introduce a health spending account with medical cannabis coverage included, and introduced a company-wide shares option plan for all permanent employees. Deborah is a strong proponent of diversity and a member of the Women’s Executive Network and Women of Influence, the Strategic Capability Network, and the London Chamber of Commerce.  Deborah holds an Honors Bachelor of Arts in Psychology and a Master of Industrial Relations from Western University. She is also a Certified Talent Management Practitioner (CTMP) through the CTMP Society of Canada.Information about upcoming corporate events can be found here. Access WeedMD’s latest investor deck here. About WeedMD Inc.WeedMD Inc. is the publicly-traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., federally-licensed producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as a fully-licensed 26,000 sq. ft. Aylmer, Ontario processing facility, specializing in cannabis extraction. With the addition of Starseed, a medical-centric operator based in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well as seven provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold.Follow WeedMD, Color Cannabis & Starseed: LinkedIn: https://ca.linkedin.com/company/weedmd Twitter: https://twitter.com/WeedMD Instagram: https://www.instagram.com/weedmd/ Instagram: https://www.instagram.com/callitcolor/ & Instagram: https://www.instagram.com/starseedca/For further information, please contact:For Investor Enquiries: Valter Pinto Managing Director KCSA Strategic Communications 1-212-896-1254 weedmd@kcsa.comFor Media Enquiries: Marianella delaBarrera VP, Communications & Corporate Affairs 416-897-6644 marianella@weedmd.comForward Looking Information This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy. The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASEA photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/57b6914d-c54c-4517-9c16-4ac1a04703d3

  • WeedMD Appoints Veteran Finance Executive to its Board of Directors
    GlobeNewswire

    WeedMD Appoints Veteran Finance Executive to its Board of Directors

    Distinguished business leader and former Deloitte partner Luciano (Lu) Cacioppo appointed as an independent director and chair of Company’s Audit Committee WeedMD Appoints Veteran Finance Executive to Board of Directors Distinguished business and community leader Luciano (Lu) Cacioppo, FCPA, CA, joins WeedMD's Board of Directors as an independent director, and chair of Company's Audit Committee.TORONTO, Oct. 19, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis is pleased to announce the appointment of veteran finance executive Lu Cacioppo, FCPA, CA, to its Board of Directors (the “Board”) and chair of WeedMD’s Audit Committee. Lu joins the Board as an independent director and is a nominee of 2437653 Ontario Inc. (the “LiUNA Pension Fund of Central and Eastern Canada”) pursuant to the Nomination Rights and Voting Agreement dated December 20, 2019.“WeedMD is steadily executing its business plan with a focused approach and we are thrilled to welcome Lu as an independent director and chair of our Audit Committee,” said George Scorsis, Executive Chairman of WeedMD. “Lu is a highly-regarded business and community leader that brings more than 30 years of valuable experience and insight in finance, capital markets, and corporate governance. As a former Deloitte partner, Lu’s solid industry reputation and sharp business acumen comes at a timely juncture as we accelerate our profitability goals and ready the company for long-term growth.”“As a long-time observer of the cannabis industry, I’ve admired companies that can operate with a disciplined, customer-centric approach while balancing growth with fiscal rigor,” said Mr. Cacioppo. “WeedMD has all the necessary fundamentals in place to accelerate revenue growth and move towards profitability. I’m thrilled to be joining the board and to contributing to the Company’s success as we look to continue building long-term shareholder value.”More about Lu CacioppoCurrently the vice chair and managing partner at private equity firm Beringer Capital, Lu advises and provides value-added solutions to companies around the world in various industries including technology, media, real estate, automotive and professional services. Prior to joining Beringer Capital, Lu served as the leader of the Deloitte Private practice in the Ontario region and the managing partner of its small and medium-sized enterprises (SME) program. In this role, he led a national team that specialized in delivering audit and assurance, tax, consulting and risk, and financial advisory services to private companies. Lu has a distinguished FCPA (Fellow of the Chartered Professionals Accountants) designation which is awarded to CPAs that are outstanding leaders in both business and community. Among his many community involvements: St. Joseph’s Health System Board, Dr. Bob Kemp Hospice, the Canadian Accredited Independent Schools and the Sons of Italy Charitable Foundation.Information about upcoming corporate events including earnings conference call details can be found here. Access WeedMD’s latest investor deck  here. About WeedMD Inc.WeedMD Inc. is the publicly-traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., federally-licensed producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as a fully-licensed 26,000 sq. ft. Aylmer, Ontario processing facility, specializing in cannabis extraction. With the addition of Starseed, a medical-centric operator based in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well as seven provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold.Follow WeedMD, Color Cannabis & Starseed: LinkedIn: https://ca.linkedin.com/company/weedmd Twitter: https://twitter.com/WeedMD Instagram: https://www.instagram.com/weedmd/ Instagram: https://www.instagram.com/callitcolor/ & Instagram: https://www.instagram.com/starseedca/For further information, please contact: For Investor Enquiries: Valter Pinto Managing Director KCSA Strategic Communications 1-212-896-1254 weedmd@kcsa.comFor Media Enquiries: Marianella delaBarrera VP, Communications & Corporate Affairs 416-897-6644 marianella@weedmd.comForward Looking Information This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy. The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASEA photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/26396820-fe16-416c-91d3-be6bbae8639f

  • WeedMD Announces Cannabis 2.0 Supply Partnership with PAX LABS®
    GlobeNewswire

    WeedMD Announces Cannabis 2.0 Supply Partnership with PAX LABS®

    Pods for PAX® ERA® and ERA PRO™ cannabis vaporizers to be filled and sold by Company using its terpene-rich biomass and co-marketed under Color Cannabis and Starseed brands WeedMD Announces Cannabis 2.0 Supply Partnership with PAX LABS WeedMD is a brand partner and supplier for the PAX® ERA® Collection in Canada, which includes the closed-loop PAX® ERA® and ERA PRO™ devices. TORONTO, Oct. 13, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis is pleased to announce it has entered into a supply agreement with Pax Labs, Inc. ("PAX"), a leader in premium cannabis vaporizer technology, with award-winning devices for both oil concentrates and flower. WeedMD will become a brand partner and supplier for the PAX® ERA® Collection in Canada, which includes the closed-loop PAX® ERA® and ERA PRO™ devices. WeedMD’s partnership with PAX will accelerate the growth of the Company's Cannabis 2.0 product strategy as it expands into new formats using its low-cost, quality-produced, strain-specific biomass. As the latest cultivator to launch PAX Era Pods in Canada, WeedMD will produce cannabis oil pods for the ‘pen-and-pod’ vaporizer devices at the Company’s state-of-the-art extraction hub in Aylmer, Ontario. WeedMD will sell Color Cannabis, and Starseed Medicinal-branded oil pods nationwide through supply arrangements with retailers, and its online medical store."As we continue to enhance and expand our new cannabis formats and brand reach for Color and Starseed, we’re proud to partner with PAX, and we are looking forward to adding its line up to our growing portfolio of 2.0 brands,” said Angelo Tsebelis, CEO of WeedMD. “PAX is widely known as a premier innovator in cannabis product vaporizers. With its award-winning brand appeal and consumer-favoured hardware offerings, PAX is perfectly suited to be paired with WeedMD’s quality-produced, terpene-rich cannabis concentrates.”"PAX is thrilled to welcome WeedMD, a leader in the medical cannabis channel in Canada, to our Canadian Brand Partner family," said Tim Pellerin, General Manager, Canada & International at PAX Labs. "WeedMD has a record of delivering high-quality, novel products to patients and consumers in varied consumption methods. We look forward to growing together across all channels, rooted in our shared rigor in quality, innovation, and access to information, to bring these products to medical and adult-use consumers across the country."PAX Era Pods, for use with PAX's high-tech oil vaporizers, are dependable, leak-resistant and designed to be clog-free. PAX is a market leader with over two million devices sold worldwide and an established reputation as the best-selling pen-and-pod system in the U.S.Information about upcoming corporate events including earnings conference call details can be found here. Access WeedMD’s latest investor deck  here. About WeedMD Inc. WeedMD Inc. is the publicly-traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., federally-licensed producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as a fully-licensed 26,000 sq. ft. Aylmer, Ontario processing facility, specializing in cannabis extraction. With the addition of Starseed, a medical-centric operator based in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well as seven provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold.Follow WeedMD, Color Cannabis & Starseed:LinkedIn: https://ca.linkedin.com/company/weedmd Twitter: https://twitter.com/WeedMD Instagram: https://www.instagram.com/weedmd/ Instagram: https://www.instagram.com/callitcolor/ & Instagram: https://www.instagram.com/starseedca/                                                    For further information, please contact:For Investor Enquiries: Valter Pinto Managing Director KCSA Strategic Communications 1-212-896-1254 weedmd@kcsa.comFor Media Enquiries: Marianella delaBarrera VP, Communications & Corporate Affairs 416-897-6644 marianella@weedmd.comForward Looking Information This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy. The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASEA photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f34b7ba7-a590-4ee4-b988-4a9084e01c15.